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Résumé en
anglais
CKD frequently leads to chronic cardiac dysfunction. This complex relationship has
been termed as cardiorenal syndrome type 4 or cardio-renal link. Despite numerous
studies and reviews focused on the pathophysiology and therapy of this syndrome,
the role of arterial stiffness has been frequently overlooked. In this regard, several
pathogenic factors, including uremic toxins (, uric acid, phosphates, endothelin-1,
advanced glycation end-products, and asymmetric dimethylarginine), can be
involved. Their effect on the arterial wall, direct or mediated by chronic
inflammation and oxidative stress, results in arterial stiffening and decreased
vascular compliance. The increase in aortic stiffness results in increased cardiac
workload and reduced coronary artery perfusion pressure that, in turn, may lead to
microvascular cardiac ischemia. Conversely, reduced arterial stiffness has been
associated with increased survival. Several approaches can be considered to reduce
vascular stiffness and improve vascular function in patients with CKD. This review
primarily discusses current understanding of the mechanisms concerning uremic
toxins, arterial stiffening, and impaired cardiac function, and the therapeutic
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